scPharmaceuticals Inc.

SCPH

scPharmaceuticals Inc.

SCPH

Insider Sentiment (TTM):

Last Purchase:2024-08-13Last Sale:2022-10-10Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-09-30Institutional Shares Owned:36,934,356Shares Outstanding:53,719,662Institutional Ownership Pct.:68.75%

Earnings Market Reaction:

Filing Date:N/APrice on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Assets
Cash And Cash Equivalents At Carrying Value	41	58	76	91	39	58	47	35	71	75	71	41
Short Term Investments	-	-	0	-	-	-	29	55	32	41	47	4
Restricted Cash Current	-	-	-	-	-	-	-	-	-	-	0	-
Accounts Receivable Net Current	19	14	12	9	6	6	4	4	2	3	-	-
Assets Current
Assets Current	79	89	106	123	63	77	93	104	114	127	123	47
Inventory Net	15	14	14	18	15	10	9	7	6	4	1	-
Prepaid Expense Current	4	3	4	3	2	2	2	2	2	3	2	2
Other Assets Current	-	-	-	-	-	-	-	-	-	-	-	0
Restricted Cash Noncurrent	-	-	-	-	-	-	-	-	-	-	-	0
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	2	0	0	1	1
Assets	80	91	108	125	65	78	94	106	114	127	124	48
Liabilities And Stockhold…
Accounts Payable Current	4	5	4	5	5	3	4	3	1	2	2	1
Accrued Liabilities Current	16	11	11	10	7	9	9	7	5	6	5	5
Liabilities Current
Liabilities Current	20	16	15	15	13	12	13	11	7	8	7	17
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	10
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	1	1
Other Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	1
Long Term Debt Noncurrent	51	51	51	51	40	39	39	38	38	37	37	-
Derivative Liabilities Noncurrent	-	-	0	0	2	1	4	6	6	7	8	-
Operating Lease Liability Noncurrent	1	1	1	1	1	1	1	1	0	0	0	0
Other Liabilities Noncurrent	-	-	0	0	0	0	0	0	0	0	0	-
Liabilities	102	96	94	94	56	54	57	57	51	52	52	17
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	383	381	380	378	322	320	319	317	315	314	299	248
Stockholders Equity
Stockholders Equity	-21	-5	13	31	9	25	37	49	63	76	72	31
Retained Earnings Accumulated Deficit	-404	-386	-366	-348	-313	-295	-281	-268	-252	-238	-227	-217
Accumulated Other Comprehensive Income Loss Net Of…	-	-	0	-	-	-	-0	-0	-0	0	0	-
Liabilities And Stockholders Equity	80	91	108	125	65	78	94	106	114	127	124	48
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	53	50	50	50	36	36	36	36	36	36	34	27
Shares Outstanding	53	50	50	50	36	36	36	36	36	36	34	27

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

No price variance data available.

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Liquidity Ratios
Current Ratio	3.85	5.48	7.12	8.08	4.84	6.21	7.08	9.53	17.12	16.38	16.63	2.75
Quick Ratio	2.96	4.40	5.94	6.67	3.48	5.26	6.22	8.73	15.96	15.56	16.15	2.65
Working Capital	58.30M	73.04M	90.97M	108.07M	49.70M	64.21M	79.80M	93.39M	106.94M	118.93M	115.89M	29.99M
Leverage & Debt
Debt to Equity	-4.77	-18.74	7.07	3.07	6.08	2.19	1.54	1.16	0.80	0.68	0.71	0.56
Interest Coverage TTM	-10.87	-9.73	-8.56	-7.79	-7.20	-7.22	-6.82	-6.21	-7.10	-8.53	-10.95	-17.00
Debt Ratio	1.27	1.06	0.88	0.75	0.86	0.69	0.61	0.54	0.44	0.40	0.42	0.36
Efficiency & Turnover
Asset Turnover TTM	0.69	0.50	0.36	0.26	0.27	0.17	0.12	0.10	0.04	0.02	0.00	0.00
Days Sales Outstanding TTM	93.22	85.32	81.42	80.72	58.63	90.84	120.54	203.26	158.78	531.49	-	-
Receivables Turnover TTM	3.92	4.28	4.48	4.52	6.23	4.02	3.03	1.80	2.30	0.69	-	-
Per Share Metrics
Diluted EPS TTM	-1.71	-1.69	-1.91	-1.72	-1.56	-1.48	-1.42	-1.30	-1.16	-1.07	-1.30	-1.27
Free Cash Flow Per Share TTM	-1.23	-1.30	-1.58	-1.52	-1.71	-1.55	-1.54	-1.44	-1.31	-1.16	-1.22	-1.09
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	68.46%	68.92%	68.73%	69.72%	71.15%	71.69%	71.96%	-	-	-	-	-
Operating Profit Margin TTM	-133.16%	-158.82%	-178.29%	-210.35%	-251.09%	-338.58%	-407.53%	-662.13%	-1,210.38%	-1,961.75%	-	-
Net Profit Margin TTM	-183.55%	-216.24%	-234.36%	-264.60%	-252.18%	-327.29%	-403.22%	-670.21%	-1,209.78%	-1,954.29%	-	-
Growth Metrics
Net Revenue Growth (1Y)	107.79%	138.10%	167.28%	303.87%	549.77%	754.68%	-	-	-	-	-	-
Net Income Growth (1Y)	51.24%	57.31%	55.35%	59.45%	35.44%	43.14%	48.79%	43.94%	43.06%	40.66%	31.40%	22.48%
EPS Growth (1Y)	9.75%	14.16%	34.39%	32.74%	34.43%	38.91%	9.55%	1.75%	1.23%	1.84%	26.74%	22.28%
Calculated Values
Free Cash Flow TTM	-65.88M	-70.00M	-70.56M	-70.56M	-66.58M	-60.49M	-59.29M	-55.93M	-50.69M	-43.72M	-34.60M	-29.87M
Net Debt	10.39M	-6.49M	-24.31M	-40.39M	1.49M	-19.06M	-8.00M	3.22M	-33.61M	-38.20M	-34.45M	-31.59M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-08-13Purchase

Owner: Orbimed, Capital Gp Vi Ll…

Title: -

Shares: 500,000

Price/Share: $4.00

Value: $2,000,000.00

Shares Owned: 5,806,670

Relationship: TenPercentOwner

Ownership: Indirect

2022-11-25Purchase

Owner: Orbimed, Advisors Llc, Or…

Title: -

Shares: 762,380

Price/Share: $5.25

Value: $4,002,495.00

Shares Owned: 5,328,328

Relationship: TenPercentOwner

Ownership: Indirect

2022-10-10Sale

Owner: Diekman, John D, 5Am Vent…

Title: -

Shares: 562,466

Price/Share: $4.09

Value: $2,300,485.94

Shares Owned: 92,983

Relationship: TenPercentOwner

Ownership: Indirect

2022-09-07Sale

Owner: 5Am, Partners Iv, Llc, Ro…

Title: -

Shares: 200,000

Price/Share: $4.75

Value: $950,000.00

Shares Owned: 113,269

Relationship: TenPercentOwner

Ownership: Indirect

2022-04-11Sale

Owner: 5Am, Opportunities I (Gp)…

Title: -

Shares: 270,000

Price/Share: $5.00

Value: $1,350,000.00

Shares Owned: 120,966

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-08-13	Orbimed, Capital Gp Vi Ll…	TenPercentOwner	-	Indirect	Purchase	500,000	4.00	$2,000,000.00	5,806,670	4
2022-11-25	Orbimed, Advisors Llc, Or…	TenPercentOwner	-	Indirect	Purchase	762,380	5.25	$4,002,495.00	5,328,328	4
2022-10-10	Diekman, John D, 5Am Vent…	TenPercentOwner	-	Indirect	Sale	562,466	4.09	$2,300,485.94	92,983	4
2022-09-07	5Am, Partners Iv, Llc, Ro…	TenPercentOwner	-	Indirect	Sale	200,000	4.75	$950,000.00	113,269	4
2022-04-11	5Am, Opportunities I (Gp)…	TenPercentOwner	-	Indirect	Sale	270,000	5.00	$1,350,000.00	120,966	4
2021-12-03	Khattar, Jack A.	Director	-	Direct	Purchase	5,000	3.91	$19,550.00	5,000	4
2021-12-03	Tucker, John H	Director,Officer	President and CEO	Direct	Purchase	10,000	3.96	$39,600.00	46,962	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-09-30

68.75%

Inst. Shares: 36,934,356

Shares Outstanding: 53,719,662

2025-06-30

69.07%

Inst. Shares: 37,105,333

Shares Outstanding: 53,719,662

2025-03-31

67.78%

Inst. Shares: 36,380,915

Shares Outstanding: 53,676,376

2024-12-31

86.64%

Inst. Shares: 38,570,396

Shares Outstanding: 44,519,669

2024-09-30

77.49%

Inst. Shares: 36,079,421

Shares Outstanding: 46,558,474

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-09-30	36,934,356	53,719,662	68.75%
2025-06-30	37,105,333	53,719,662	69.07%
2025-03-31	36,380,915	53,676,376	67.78%
2024-12-31	38,570,396	44,519,669	86.64%
2024-09-30	36,079,421	46,558,474	77.49%
2024-06-30	26,704,683	38,984,745	68.50%
2024-03-31	25,343,992	38,952,131	65.06%
2023-12-31	26,784,237	38,513,747	69.54%
2023-09-30	28,840,367	38,760,895	74.41%
2023-06-30	27,730,041	38,692,624	71.67%
2023-03-31	22,305,026	37,800,960	59.01%
2022-12-31	19,762,869	28,358,502	69.69%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

scPharmaceuticals Inc. (SCPH) — SEC Financial Statements & Analysis

scPharmaceuticals Inc. (SCPH) is a pharmaceutical preparations company, incorporated in DE. scPharmaceuticals Inc. trades on None as: SCPH. Based on its latest SEC filing (Form 10-Q, period ending 2025-06-30), scPharmaceuticals Inc. reported a 107.79% year-over-year revenue growth, a Gross Profit Margin of 68.46% (TTM), a Debt-to-Equity ratio of -4.77x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 107.79%
Gross Profit Margin TTM: 68.46%
Debt To Equity: -4.77x

Data as of 2025-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is scPharmaceuticals Inc. in?

scPharmaceuticals Inc. (SCPH) operates in the Pharmaceutical Preparations industry.

What exchange does SCPH trade on?

scPharmaceuticals Inc. (SCPH) trades on the None.

Where is scPharmaceuticals Inc. incorporated?

scPharmaceuticals Inc. is incorporated in DE.